2019, Jan. 24-26: Liver Pathology: Translating a World of Colors into Clinically Relevant Pathology Reports
Jan. 24-26, 2019
17 CMEs / 17 SAMs
The microscopic pattern of liver biopsies for non-neoplastic diseases has changed with increasing emphasis on steatohepatitis, fibrosis regression and drug-induced liver disease. The reasons for these changes (based on consultative cases at several large medical centers) include classification of an hepatic pattern of injury, primary biliary cholangitis, fatty liver disease, autoimmune hepatitis, etiology of cirrhosis and transplant pathology (unpublished data). Among the neoplastic cases, hepatocellular carcinoma, cholangiocarcinoma/metastatic adenocarcinoma and hepatocellular adenoma are the leading areas that cause problems in diagnosis for practicing pathologists. Advances in radiologic techniques facilitate targeting smaller lesions, necessitating judicious use of immunohistochemistry. In the last few years, characteristic molecular changes have been described in a variety of liver tumors and are increasingly being used for diagnosis. Take advantage of this fantastic mentoring opportunity to study liver interactively with experts who can improve your performance and enhance your practice. You should consider taking this course in contiguity with Twists and Turns of Problematic GI Pathology and How to Find Your Way Out!, directed by Dr. Gregory Y. Lauwers, H. Lee Moffitt Cancer Center/University of South Florida, January 27-30, 2019.
- Formulate pattern diagnosis for hepatitis and biliary diseases, and narrow the differential diagnosis based on clinical features
- Recognize liver infections and common features of liver involvement in systemic diseases
- Obtain appropriate immunohistochemical stains for focal nodular hyperplasia, hepatocellular adenoma and hepatocellular carcinoma
- Distinguish benign and malignant biliary proliferations on biopsies and frozen sections
Sanjay Kakar, M.D.
University of California, San Francisco (UCSF)
- Dhanpat Jain, M.D.
Yale University School of Medicine
- Laura W. Lamps, M.D.
University of Michigan Hospital
- Michael Torbenson, M.D.
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this live activity for a maximum of 17 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABPath requirements for Continuing Certification (CC).
Physicians can earn a maximum of 17 SAM credit hours.
USCAP records courses at the Interactive Learning Center for future educational purposes. By registering for this course, you consent that your likeness may be used by USCAP.
For cancellations received on or before one month before the event, a $50 administrative charge will be due. After that date, cancellations will be assessed an administrative charge of 25% of the total registration fee. There will be no refunds for cancellations after one week before the event.
The Academy is not responsible for travel expenses incurred as a result of an event cancellation.